$330 Million is the total value of Bill & Melinda Gates Foundation's 11 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVAC | CUREVAC N V | $107,600,000 | -37.1% | 3,134,780 | 0.0% | 32.65% | -34.9% | |
| IMCR | IMMUNCORE HLDGS PLCads | $55,800,000 | +160.7% | 576,923 | 0.0% | 16.93% | +170.2% | |
| LUMIRADX LIMITED | $49,700,000 | +7.8% | 5,574,059 | 0.0% | 15.08% | +11.7% | ||
| BNTX | BIONTECH SEsponsored ads | $38,300,000 | -5.7% | 148,674 | 0.0% | 11.62% | -2.2% | |
| New | EXSCIENTIAads | $31,400,000 | – | 1,590,909 | +100.0% | 9.53% | – | |
| VIR | VIR BIOTECHNOLOGY INC | $28,400,000 | -3.7% | 677,777 | 0.0% | 8.62% | -0.2% | |
| BFLY | BUTTERFLY NETWORK INC | $6,800,000 | -35.8% | 1,011,003 | 0.0% | 2.06% | -33.5% | |
| SERA PROGNOSTICS INC | $5,400,000 | -37.9% | 779,814 | 0.0% | 1.64% | -35.7% | ||
| BCEL | ATRECA INC | $4,200,000 | -51.7% | 1,396,644 | 0.0% | 1.27% | -50.0% | |
| AMRS | AMYRIS INC | $1,600,000 | -60.0% | 292,398 | 0.0% | 0.48% | -58.6% | |
| ZY | ZYMERGEN INC | $400,000 | -50.0% | 59,970 | 0.0% | 0.12% | -48.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CUREVAC N V | 12 | Q3 2023 | 58.0% |
| VIR BIOTECHNOLOGY INC | 12 | Q3 2023 | 32.0% |
| BIONTECH SE | 12 | Q3 2023 | 35.8% |
| ATRECA INC | 12 | Q3 2023 | 5.3% |
| AMYRIS INC | 12 | Q3 2023 | 1.2% |
| IMMUNCORE HLDGS PLC | 11 | Q3 2023 | 35.7% |
| BUTTERFLY NETWORK INC | 11 | Q3 2023 | 3.8% |
| LUMIRADX LTD | 8 | Q3 2023 | 18.0% |
| EXSCIENTIA | 8 | Q3 2023 | 13.3% |
| ZYMERGEN INC | 6 | Q3 2022 | 0.3% |
View Bill & Melinda Gates Foundation's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LumiraDx Ltd | August 03, 2022 | 19,859,773 | 15.8% |
| Atreca, Inc. | February 16, 2021 | 1,396,644 | 4.7% |
| Liquidia Technologies Inc | February 12, 2020 | 119,678 | 0.5% |
| X4 Pharmaceuticals, Inc | March 15, 2019 | 120,363 | 1.8% |
| Arsanis, Inc. | February 13, 2018 | 722,179 | 5.1% |
View Bill & Melinda Gates Foundation's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| SC 13D | 2022-08-03 |
| SC 13G | 2022-07-15 |
| 13F-HR | 2022-05-13 |
View Bill & Melinda Gates Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.